Detection of cytogenetic aberrations in CD 90 (Thy-1) positive and negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias.

被引：0
|
作者：
Brendel, C [1 ]
Mohr, B [1 ]
Schimmelpfennig, C [1 ]
Müller, J [1 ]
Bornhauser, M [1 ]
Ritter, M [1 ]
Ehninger, G [1 ]
Neubauer, A [1 ]
机构：
[1] Tech Univ Dresden, Klinikum Carl Gustav Carus, Mol Diagnost 1, D-01307 Dresden, Germany
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3581
引用
收藏
页码：141B / 141B
页数：1
相关论文
共 50 条
  • [1] Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias
    C Brendel
    B Mohr
    C Schimmelpfennig
    J Müller
    M Bornhäuser
    M Schmidt
    M Ritter
    G Ehninger
    A Neubauer
    Leukemia, 1999, 13 : 1770 - 1775
  • [2] Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias
    Brendel, C
    Mohr, B
    Schimmelpfenning, C
    Müller, J
    Bornhäuser, M
    Schmidt, M
    Ritter, M
    Ehninger, G
    Neubauer, A
    LEUKEMIA, 1999, 13 (11) : 1770 - 1775
  • [3] Optimizing the CD34(+) and CD34(+)Thy-1(+) stem cell content of peripheral blood collections
    Stewart, AK
    Imrie, K
    Keating, A
    Anania, S
    Nayar, R
    Sutherland, DR
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (14) : 1619 - 1627
  • [4] High frequency of CD90/Thy-1 expression on blast cells of myelodysplastic syndromes and high risk acute myeloid leukemias.
    Buccisano, F
    Rossi, FM
    Venditti, A
    Del Poeta, G
    Rupolo, M
    Berretta, M
    Cox, MC
    Abbruzzese, E
    Tamburini, A
    Maurillo, L
    Amadori, S
    Gattei, V
    BLOOD, 2002, 100 (11) : 195A - 195A
  • [5] CHARACTERIZATION OF THY-1 (CDW90) EXPRESSION IN CD34(+) ACUTE-LEUKEMIA
    HOLDEN, JT
    GELLER, RB
    FARHI, DC
    HOLLAND, HK
    STEMPORA, LL
    PHILLIPS, CN
    BRAY, RA
    BLOOD, 1995, 86 (01) : 60 - 65
  • [6] Identification of CD34(+) subsets after glycoprotease selection: Engraftment of CD34(+)Thy-1(+)Lin(-) stem cells in fetal sheep
    Sutherland, DR
    Yeo, EL
    Stewart, AK
    Nayar, R
    DiGiusto, R
    Zanjani, E
    Hoffman, R
    Murray, LJ
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (07) : 795 - 806
  • [7] OPTIMIZING THE CD34(+), THY-1(+) CELL CONTENT OF PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS
    STEWART, AK
    IMRIE, K
    PRINCE, HM
    ANANIA, S
    KEATING, A
    SUTHERLAND, DR
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 786 - 786
  • [8] Prolonged immunosuppression after CD34(+) or CD34(+)/Thy-1(+)/Lin(*) selected autologous peripheral blood stem cell (PBSC) transplants (Tx) for multiple myeloma
    Siegel, D
    Mehta, J
    Anaissie, E
    Desikan, KR
    Fassas, A
    Jagannath, S
    Singhal, S
    Tricot, G
    Munshi, N
    Barnhart, S
    Hood, S
    Spoon, D
    Mattox, S
    Barlogie, B
    BLOOD, 1997, 90 (10) : 487 - 487
  • [9] Preferential mobilization and yield of normal donor primitive CD34(+) Thy-1(dim) and CD34(+) Thy-1(dim) CD38(-) progenitor cells and lymphoid subsets for allogeneic blood stem cell transplantation: Possible predictors of clinical outcome
    Korbling, M
    Durett, A
    Huh, YO
    Mirza, N
    Anderlini, P
    Seong, D
    Przepiorka, D
    Deisseroth, A
    Champlin, R
    BLOOD, 1995, 86 (10) : 414 - 414
  • [10] CD34(+)Thy-1(+)Lin human and relevant murine stem cell separation and expansion - The SyStemix experience.
    Juttner, CA
    Tsukamoto, A
    Tushinski, B
    Tsao, M
    Szilvassy, SJ
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 144 - 144
12345